In this podcast, Lori Kostich, CCC-SLP, from the Mandell Center for Multiple Sclerosis Treatment and Research, discusses how she identifies and manages dysphagia among her patients with multiple sclerosis, and when neurologists should refer patients to a speech-language pathologist for dysphagia-related concerns.
Neurology Consultant spoke with Helen Tremlett, PhD, from the University of British Columbia, whose recent study adds to increasing evidence of a multiple sclerosis prodrome. Dr Tremlett discussed this topic during the Paty Lecture at the ECTRIMS/ACTRIMS 8th Joint Triennial Meeting, or MSVirtual2020.
In this podcast, Dr Charvet and Dr Eilam-Stock discuss the findings from their study, which provided evidence of early neuropsychological markers of cognitive involvement among patients with multiple sclerosis.
Patricia K. Coyle, MD, on Fluid and Neurophysiological Biomarkers for the Early Diagnosis of Progression of RRMS to SPMS
She discusses the current state of evidence on the role of fluid and neurophysiological biomarkers in the early diagnosis of progression of relapsing-remitting MS to secondary progressive MS, and more.
Pavan Bhargava, MD, discusses how he and his colleagues are treating patients with multiple sclerosis via telemedicine amid the ongoing pandemic.
In this podcast, Dr DeLuca discusses the clinical course and prognosis of cognitive impairment in relapsing-remitting multiple sclerosis, as well as cognitive rehabilitation tools that are currently available and on the horizon.
Mona Bostick, RDN, LDN, discusses nutrition and the role of multidisciplinary nutrition care for patients with multiple sclerosis. She recently gave a talk on this topic at the 2020 CMSC Virtual Meeting.
In this podcast, Dr Coyle reviews the diagnosis and clinical course of progressive multiple sclerosis (MS), pearls for distinguishing it from its differential diagnosis, and the importance of multidisciplinary care in the long-term management of progressive MS.
Michelle Cameron, MD, PT, talks about the federal and state legalities surrounding cannabinoid use, how cannabinoids go through the FDA approval process, and how cannabinoids can be used to treat symptoms of multiple sclerosis.
Kristen Krysko, MD, on Newer vs Injectable Disease-Modifying Therapies for Initial Treatment of Pediatric MS
In this video, Dr Krysko discusses the findings from her study on the real-world effectiveness of newer vs injectable disease-modifying therapies among pediatric patients with multiple sclerosis.